The isolated antibody binds specifically to HER2, the pharmaceuticals and therapeutic agents containing this antibody, and the nucleic acid molecule encoding this antibody.
VN10062134BActive Publication Date: 2026-11-02ONO PHARMA CO LTD +1
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- VN1202303336
- Authority / Receiving Office
- VN · VN
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2021-11-29
- Publication Date
- 2026-11-02
- Estimated Expiration
- 2041-11-29
Abstract
The invention proposes an antibody or its antigenic fragment that binds to HER2 and is expressed on cancer cells, or a fragment of HER2, an HER2-targeted substance containing any of these, and a pharmaceutical composition containing an HER2-targeted substance.
Need to check novelty before this filing date? Find Prior Art
